Cargando…

Editorial: Altered expression of proteins in cancer: function and potential therapeutic targets, volume II

Detalles Bibliográficos
Autores principales:	Pessoa, João, Valenti, Maria Teresa, Bellance, Nadège, Chiarella, Paula, Abebe, Tamrat, Gerratana, Lorenzo, Pérez-Plasencia, Carlos, Kzhyshkowska, Julia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392946/ https://www.ncbi.nlm.nih.gov/pubmed/37534242 http://dx.doi.org/10.3389/fonc.2023.1242855

Ejemplares similares

Editorial: Altered Expression of Proteins in Cancer: Function and Potential Therapeutic Targets
por: Pessoa, João, et al.
Publicado: (2022)

Editorial: Community series in immunometabolic mechanisms underlying the severity of COVID-19, volume II
por: Kzhyshkowska, Julia, et al.
Publicado: (2023)

Editorial: Angiogenesis and tumor metastasis
por: Zhang, Qiang-Zhe, et al.
Publicado: (2023)

Editorial: Women in cancer molecular targets and therapeutics, volume II: 2022
por: Berindan-Neagoe, Ioana, et al.
Publicado: (2023)

Editorial: Biomarkers in genitourinary cancers: Volume II
por: Yuasa, Takeshi
Publicado: (2022)

Editorial: Identification of therapeutic targets and novel biomarkers in prostate cancer volume II
por: Sharad, Shashwat, et al.
Publicado: (2023)

Editorial: Novel diagnostic and therapeutic strategies in the management of cerebral gliomas, Volume II
por: Bosio, Alberto, et al.
Publicado: (2023)

Editorial: COVID-19 and hematological malignancies: Volume II
por: Wilde, Lindsay, et al.
Publicado: (2022)

Editorial: Women in gastrointestinal cancers, volume II: 2022
por: Hamdy, Nadia M., et al.
Publicado: (2023)

Editorial: Epithelial-mesenchymal transition (EMT) as a therapeutic target in cancer, Volume II
por: Zhong, Weilong, et al.
Publicado: (2023)

Editorial: Therapeutic drug monitoring and clinical toxicology of anti-cancer drugs, volume II
por: Yan, Miao, et al.
Publicado: (2023)

Editorial: Women in head and neck cancer, volume II: 2022
por: Economopoulou, Panagiota, et al.
Publicado: (2023)

Editorial: Women in molecular and cellular oncology, volume II: 2022
por: Dhar, Shilpa S.
Publicado: (2023)

Editorial: Tumor Cell Metabolism and Autophagy as Therapeutic Targets
por: Jacobo-Herrera, Nadia, et al.
Publicado: (2020)

Editorial: Molecular advances in diagnosis and treatment of CNS tumors, volume II
por: Chen, Clark, et al.
Publicado: (2023)

Editorial: Biomarkers in Genitourinary Cancers, Volume I
por: Videira, Paula Alexandra, et al.
Publicado: (2022)

Editorial: Ageing and Carcinogenesis
por: Ruggiero, Raúl A., et al.
Publicado: (2022)

Editorial: RNA and RNA modification in the pathogenesis, diagnosis and treatment of cancers, Volume II
por: Lu, Qisi, et al.
Publicado: (2023)

Editorial: Meningioma: From basic research to clinical translational study, volume II
por: Tang, Hailiang, et al.
Publicado: (2023)

Editorial: Immune-related adverse events for patients with lung cancer-volume II
por: Wang, Yusha, et al.
Publicado: (2023)

Editorial: Prognostic research and precision oncology in upper tract urothelial carcinoma-volume II
por: Yang, Tsung-Mu, et al.
Publicado: (2023)

Editorial: Bone Metastases
por: Valenti, Maria Teresa, et al.
Publicado: (2021)

Editorial: Cancer evolution: From biological insights to therapeutic opportunities
por: Davis, Andrew A., et al.
Publicado: (2022)

Editorial: Acute promyelocytic leukemia - towards a chemotherapy-free approach to cure in all patients, Volume II
por: Gill, Harinder, et al.
Publicado: (2023)

Macrophage scavenger receptors: Tumor support and tumor inhibition
por: Kazakova, Elena, et al.
Publicado: (2023)

Editorial: Advances in mathematical and computational oncology, volume III
por: Bebis, George, et al.
Publicado: (2023)

Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies
por: Pérez-Plasencia, Carlos, et al.
Publicado: (2021)

Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals
por: Shindiapina, Polina, et al.
Publicado: (2020)

Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Dissecting New Mechanism of Action Through In Vitro and In Vivo Analyses
por: López-Urrutia, Eduardo, et al.
Publicado: (2021)

A triple-drug combination induces apoptosis in cervical cancer-derived cell lines
por: Delgado-Waldo, Izamary, et al.
Publicado: (2023)

Editorial: Women in Hepato Pancreatic Biliary (HPB) Tumors: 2021, Volume I
por: Hamdy, Nadia M., et al.
Publicado: (2022)

Editorial: Women in surgical oncology vol II: 2022
por: Castagneto-Gissey, Lidia
Publicado: (2023)

Editorial: Women in skin cancer vol II: 2022
por: Ugurel, Selma, et al.
Publicado: (2023)

Editorial: Women in pediatric oncology Vol II: 2022
por: Kim, Yong-mi, et al.
Publicado: (2023)

Editorial: Immunometabolic mechanisms underlying the severity of COVID-19
por: Kzhyshkowska, Julia, et al.
Publicado: (2022)

Editorial: Antimalarial chemotherapy in the XXIst century, volume II
por: Gomes, Paula, et al.
Publicado: (2023)

Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
por: Larionova, Irina, et al.
Publicado: (2020)

Image Analysis of Circulating Tumor Cells and Leukocytes Predicts Survival and Metastatic Pattern in Breast Cancer Patients
por: Da Col, Giacomo, et al.
Publicado: (2022)

Editorial: Obesity and diabetes: implications for brain-immunometabolism, volume II
por: Gaspar, Joana M., et al.
Publicado: (2023)

Editorial: Altered epigenetic modification mediated dysregulated transcriptional networks in drug resistance
por: Brunetti, Bryce, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jtg9lghuu3k5nmk0i89cgp8a3n